IP Library › Granted Patent US 7,643,885
Granted Patent B2
US 7,643,885 · App. 11/316,064 · Granted Jan 5, 2010

Intravenous pacemaker electrode

Assignee: Siemens Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,643,885
App. No.
11/316,064
Granted
Jan 5, 2010
Kind
B2
Abstract

An intravenous pacemaker electrode has an electrode tip designed to release a drug, where the drug contains at least one of the active substances sirolimus, paclitaxel, everolimus, fibrin, rapamycin, and tacrolimus.

Claims (17)

1. An intravenous pacemaker electrode comprising an electrode tip adapted for releasing a drug,

wherein the drug is selected from the group of active substances consisting of: sirolimus, fibrin, rapamycin, tacrolimus, and combinations thereof

wherein a plurality of recesses in the electrode tip hold the drug,

wherein the active substances are introduced into the electrode tip such that the release depends on the temperature, and

wherein the plurality of recesses in the electrode tip that hold the drug are sealed by a material that degrades as a function of the temperature.

2. The pacemaker electrode according to claim 1 , wherein the amount of active substance and the release rate from the electrode tip are designed so that the active substance is released from the implanted electrode tip over a period of at least 1000 hours.

3. The pacemaker electrode according to claim 2 , wherein the active substance is released from the implanted electrode tip over a period of at least 10 years.

4. The pacemaker electrode according to claim 1 , wherein the electrode tip comprises a coating material selected from the group consisting of: platinum, carbon, titanium, aluminum dioxide, polyurethane, and a polymer.

5. The pacemaker electrode according to claim 4 , wherein the polymer is a methacrylate polymer.

6. The pacemaker electrode according to claim 1 , wherein the active substance is mixed with an electrolyte to increase the conductivity.

7. The pacemaker electrode according to claim 1 , wherein the electrode tip has different active substances at different positions on the electrode tip.

8. The pacemaker electrode according to claim 1 , wherein different active substances are introduced into the electrode tip such that they are released with a different distribution over a time interval.

9. The pacemaker electrode according to claim 1 , wherein the active substance is held in a porous structure of the electrode tip.

10. The pacemaker electrode according to claim 1 , wherein the plurality of recesses holding the active substance in the electrode tip are through-openings.

11. The pacemaker electrode according to claim 10 , wherein the through-openings are connected to an active-substance reservoir.

12. The pacemaker electrode according to claim 1 , wherein the electrode tip has a surface area of less than 5 square millimeters.

13. The pacemaker electrode according to claim 1 , wherein the electrode tip is navigated by a magnetic field.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2005
From: MASCHKE, MICHAEL
To: SIEMENS AKTIENGESELLSCHAFT
Reel/Frame 017373/0497 →
Priority Claims (1)
DE 10 2004 062 394 · Dec 23, 2004 · national
Continuity (1)
Related Publication 20060142829A1 · Jun 29, 2006